Starting in 2003, Nycomed Amersham will have two, one-year renewal options.
Prostate cancer is the most common form of cancer in men.
An estimated 8 out of 10 men diagnosed with prostate cancer are over 65. Nycomed Amersham Imaging is committed to finding innovative diagnostic and therapeutic solutions in cardiology, pulmonology, neurology and oncology. The Company is part of Nycomed Amersham plc, the world leader in in-vivo diagnostic imaging and life sciences. Premier is one of North America's leading strategic alliances of hospitals and healthcare systems across the country, representing more than 200 owners, the 900 hospitals and healthcare facilities they operate, and approximately 900 other affiliated hospital and healthcare organisations. Understanding Brachytherapy Prostate brachytherapy, also referred to as seed implantation, is a minimally invasive outpatient procedure in which radioactive seeds are implanted within the prostate, where they irradiate the tumor.